Albion VCTs Raise £90 Million to Back UK High-Growth Companies
  • News
  • Europe

Albion VCTs Raise $119 Million to Back UK High-Growth Companies

The oversubscribed offer will fund deeptech, healthcare, and B2B software startups.

3/18/2026
Othmane Taki
Back to News

Albion Capital has successfully completed its latest top-up offer for its three Venture Capital Trusts (VCTs), securing a fully subscribed $119 Million. This significant capital raise underscores strong investor confidence in Albion's strategy and the broader UK technology sector. The funds are earmarked for investment into a new generation of high-growth British companies, reinforcing the VCTs' role in fueling national innovation.


Overwhelming Investor Demand

The fundraising campaign, which launched on November 3, 2025, experienced exceptional demand from investors, quickly surpassing its initial £60 million target. In response, the Boards exercised a $40 million over-allotment facility to accommodate the high level of interest. The offer's closure on March 16, 2026, marks a resounding success, reflecting the compelling proposition of VCTs in the current economic climate.

Following the successful closure, the allotment for all valid applications is scheduled to occur on March 27, 2026, for the current tax year. The newly issued shares are then expected to be admitted for trading on the London Stock Exchange’s main market on or around April 1, 2026. This swift timeline ensures that capital can be deployed efficiently while providing liquidity for investors.

Strategic Deployment in High-Growth Sectors

The newly raised $119 Million will be strategically deployed across Albion Capital’s core conviction sectors, including deeptech, healthcare, and B2B software. This focus allows investors to gain exposure to a diversified portfolio of innovative businesses, ranging from early-stage disruptors to established scale-ups. The capital injection will support ambitious founders in fields where the United Kingdom is a recognized global leader.

Albion's portfolio already includes several industry leaders, demonstrating the success of its investment thesis. Notable holdings include Quantexa, a global pioneer in decision intelligence solutions, and Oviva, a leading European digital health company that recently raised a $265 million Series D round. Recent activity also includes significant growth rounds for innovators like Gravity and TransFICC, highlighting a dynamic and thriving portfolio.

A Proven Track Record of Value Creation

This fundraise follows a period of significant portfolio momentum, underscoring Albion's ability to nurture growth. Over the past three years, an impressive 64 percent of its portfolio companies have successfully transitioned from the growth stage to the scale-up stage. This track record of advancing businesses is a key factor in attracting sustained investor support for the VCTs.

Over the last five years, the Albion VCTs have raised over $538 million, consistently delivering value to shareholders. As of June 2025, the trusts delivered average annual returns of 6.5% over five years and 6.9% over ten years, excluding initial tax relief. This consistent performance showcases a robust model for investing in companies with transformational growth potential while providing attractive returns.

Market Perspective and Future Outlook

Will Fraser-Allen, Managing Partner at Albion Capital, noted that reaching the £90 million hard cap reflects growing recognition of VCTs as an effective vehicle. He stated that they empower investors to back the next generation of UK entrepreneurs while targeting long-term, tax-efficient returns. In an environment where both growth and tax efficiency are paramount, VCTs offer a compelling proposition for backing British breakthroughs.

Looking ahead, Fraser-Allen confirmed that Albion has a strong pipeline of investment opportunities across its core sectors. The firm is well-positioned to deploy this new capital into companies driving significant technological and scientific progress. This strategy aims to support ambitious founders, create substantial value for shareholders, and contribute positively to the wider UK economy.


In conclusion, the successful $119 Million fundraise by the Albion VCTs is a powerful endorsement of its investment strategy and the vitality of the UK's innovation ecosystem. It equips Albion Capital with significant resources to continue identifying and scaling transformative companies. This achievement not only benefits its shareholders but also provides crucial fuel for the nation's most promising technology ventures.